Ask VialBase
hormone

Glandokort

Also known as: Glandokort peptide, adrenal peptide bioregulator, adrenal cortex Cytomax
Anecdotal evidence FDA: not-FDA-approved WADA: Not listed

Glandokort is a natural adrenal-cortex polypeptide complex sold as a "Cytomax" in the Khavinson bioregulator family — a peptide mixture extracted from the adrenal tissue of young animals and marketed to normalise cortisol rhythm and improve adrenal resilience and energy in chronic-fatigue or burnout states. Unlike the better-studied bioregulators, no Glandokort-specific study is indexed in PubMed — its proposed epigenetic, adrenal-regulating mechanism is inferred from the broader organ-extract class. It is not FDA-approved. For educational purposes only. Not medical advice. Glandokort is presented as an adrenal-cortex-tropic Cytomax: a natural tissue-derived peptide complex (not a single defined sequence) whose proposed action

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight —
Half-life ~minutes estimated;
CAS number —
Route Subcutaneous · Oral subcutaneous preferred
02

Mechanism

Natural adrenal-cortex polypeptide complex ("Cytomax") in the Khavinson bioregulator family, extracted from the adrenal tissue of young animals. Like the other organ-extract Cytomaxes it is proposed to act epigenetically — delivering a mixture of adrenal-tissue peptides that nudge gene expression in the adrenal cortex back toward a younger pattern, with the aim of normalising cortisol rhythm and adrenal resilience. Note: there is no Glandokort-specific peer-reviewed study; the mechanism is inferred from the broader short-peptide bioregulator class, not demonstrated for Glandokort itself.

03

Dosing

DOSE RANGE 10–20 mg per cycle
FREQUENCY 1×/day (vendor protocols sometimes split into divided pre-meal doses)
CYCLE LENGTH 10–20 days, cycled 2–4×/year

Traditional Khavinson-style pulsed cycles from practitioner/vendor protocols, not trial-validated doses. No controlled dosing study exists for Glandokort specifically, and no standardized, peer-reviewed reconstitution protocol exists for the Cytomax line — instructions are vendor/SKU-specific.

04

Stacking & interactions

Stress-resilience pairing (adrenal bioregulator + anxiolytic peptide)

Immune-endocrine balance (two organ-extract Cytomaxes)

Adrenal-fatigue + sleep/HPA-axis recovery

Circadian/endocrine reset alongside adrenal support

05

Sourcing

Stocks this compound Third-party tested Public COAs Positive rep

Save 15% with code VIALBASE at checkout

VialBase may earn a commission on purchases through partner links — never at additional cost to you. Full disclosure.

What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • CMP
  • CBC
  • Cortisol (AM)
DURING CYCLE
  • Cortisol (AM)
POST-CYCLE
  • CMP
  • Cortisol (AM)
Safety & Regulatory Status
FDA STATUS not-FDA-approved
WADA STATUS Not listed

Regulatory status for Glandokort may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.

Frequently Asked Questions

What is Glandokort?
Glandokort is a natural adrenal-cortex polypeptide complex sold as a "Cytomax" in the Khavinson bioregulator family — a peptide mixture extracted from the adrenal tissue of young animals. It is marketed to normalise cortisol rhythm and support adrenal resilience and energy in chronic-fatigue or burnout states. It is a Cytomax (natural organ extract), not a synthetic Cytogen.
Is there real research on Glandokort?
This is the honest part: there is no Glandokort-specific study indexed in PubMed — no clinical trial and no named in vitro or animal paper (a PubMed search for "Glandokort" returns zero records). Its proposed epigenetic, adrenal-regulating mechanism is inferred from the broader Khavinson short-peptide/organ-extract class. Treat Glandokort's specific cortisol and adrenal claims as unproven.
How does Glandokort differ from the better-studied bioregulators?
Epithalon (pineal) and Thymalin (thymus) have decades of named studies and, for the pineal/thymus pair, a controlled human mortality trial. Glandokort has none of its own — it sits in the weakest-evidence tier of the line, alongside the other organ extracts Svetinorm (liver) and Ventfort (vascular), all of which return zero PubMed records. It rides on class analogy and vendor material rather than its own data.
How is Glandokort dosed?
Practitioner and vendor protocols use short pulsed courses of about 10–20 mg per cycle for 10–20 days, repeated two to four times a year, subcutaneously or orally. Because of its HPA-axis target, AM cortisol is the suggested monitoring marker. These are traditional Khavinson-style regimens, not trial-validated doses, and no standardized reconstitution protocol exists.
Is Glandokort safe to combine with corticosteroids?
It should not be combined with prescription corticosteroids without physician supervision. Glandokort is marketed to influence the HPA (stress-hormone) axis, so layering it onto exogenous steroid therapy could in principle compound or confound adrenal effects. Given the complete absence of controlled data, anyone with diagnosed adrenal disease (Addison's, Cushing's) or on steroids should defer to a clinician.
Is Glandokort FDA-approved?
No. Glandokort is not FDA-approved and is sold only as a research chemical. It is positioned within the Russian bioregulator tradition. It is not listed by WADA and not scheduled by the DEA. Given the absence of compound-specific data, its cortisol and adrenal claims should be treated with particular caution.